Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Sunshine Heart's CEO Departs As The Firm Faces Trial Challenges

This article was originally published in The Gray Sheet

Executive Summary

The heart-assist device firm abruptly announced the departure of its CEO. Sunshine has faced multiple challenges, including slow enrollment and the need for protocol-ordered pause, with the pivotal trial for its C-Pulse system.

Advertisement

Related Content

Sunshine Heart Changes Course Again: Pauses Neuromodulation To Focus On Aquadex

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register